Skip to content

Efficacy Study of Different Interventions on Progressive Myopia After Orthokeratology Lens Wear

Efficacy Study of Different Interventions on Progressive Myopia After Orthokeratology Lens Wear

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125487
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-05-30
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

OKBC Group:None
OKRL Group:None
OK Group:None
OKA Group:None

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Age 8–12 years; 2. Both eyes SE range 0 to -6.00 D; 3. Best corrected visual acuity in both eyes >=1.0; 4. Can ensure wearing orthokeratology lenses for 8–10 hours each night; 5. No history of ocular trauma or surgery; 6. No history of acute or chronic ocular inflammation, such as keratoconjunctivitis or tear abnormalities; 7. Able to carefully care for lenses according to medical instructions and undergo regular standardized follow-ups; 8. Standard use of 0.1 g·L-1 atropine, red light, or other interventions to slow myopia progression; 9. Complete follow-up data.

Exclusion criteria

Exclusion criteria: 1. After wearing OK lenses for one year, the axial length growth of both eyes is less than 0.30mm; 2. Serious complications occur during this period (such as repeated episodes of keratitis, etc.); 3. Cases with incomplete data or lost to follow-up; 4. The range of equivalent spherical refraction (SE) in both eyes is less than -6.00D, and astigmatism is less than -2.00D; 5. Vision is unstable during OK lens wear, falling below 0.2 (LogMAR) multiple times; 6. Change of orthokeratology lens brand.

Design outcomes

Primary

MeasureTime frame
Annual axial length elongation with different intervention measures;

Secondary

MeasureTime frame
SE;Ocular Surface Examination;

Countries

China

Contacts

Public ContactMeinan He

Tianjin Medical University Eye Hospital

hmn509@tmu.edu.cn+86 22 8642 8750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026